ConcertAI: ASCO 2024 study indicates multi-AI model scalability key in streamlining of clinical trial site selection process

CAMBRIDGE, Mass., May 30, 2024 /PRNewswire/ — ConcertAI, the leader in oncology predictive and generative AI SaaS and Real-World Data (RWD) Solutions for clinical research, announced the results of the study to be presented at the ASCO Annual Meeting 2024 showing that its Digital Trial…